|
DE10207843A1
(de)
*
|
2002-02-15 |
2003-09-04 |
Schering Ag |
Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen
|
|
JP4854960B2
(ja)
|
2002-08-19 |
2012-01-18 |
ローラス セラピューティクス インコーポレーテッド |
２，４，５−三置換イミダゾールおよび抗菌薬としてのこの使用
|
|
US7582761B2
(en)
|
2002-10-17 |
2009-09-01 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
JP5095216B2
(ja)
|
2003-11-14 |
2012-12-12 |
ローラス セラピューティクス インコーポレーテッド |
アリールイミダゾールおよびその抗癌剤としての使用
|
|
DE102004026590A1
(de)
*
|
2004-06-01 |
2006-01-12 |
Siemens Ag |
Assistenzsystem für Kraftfahrzeuge
|
|
US7534796B2
(en)
|
2005-02-18 |
2009-05-19 |
Wyeth |
Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
|
|
US7582634B2
(en)
|
2005-02-18 |
2009-09-01 |
Wyeth |
7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
|
US7538113B2
(en)
|
2005-02-18 |
2009-05-26 |
Wyeth |
4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
|
US7531542B2
(en)
|
2005-05-18 |
2009-05-12 |
Wyeth |
Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
|
|
CA2611032C
(en)
|
2005-05-25 |
2012-01-17 |
Genesense Technologies Inc. |
2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
|
|
US7582636B2
(en)
|
2005-05-26 |
2009-09-01 |
Wyeth |
Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
|
|
WO2010036905A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Eisai R & D Management Co., Ltd. |
Benzoxazole compounds and methods of use
|
|
WO2010036908A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Eisai R & D Management Co., Ltd. |
Use of benzoxazole compounds in the treatment of malaria
|
|
ES2620177T3
(es)
*
|
2009-10-15 |
2017-06-27 |
Guerbet |
Agentes de formación de imágenes y su uso para el diagnóstico in vivo de enfermedades neurodegenerativas, particularmente la enfermedad de Alzheimer y enfermedades derivadas
|
|
AU2014235962A1
(en)
|
2013-03-20 |
2015-09-10 |
Aptose Biosciences Inc. |
2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
|
|
WO2015051302A1
(en)
|
2013-10-04 |
2015-04-09 |
Aptose Biosciences Inc. |
Compositions and methods for treating cancers
|
|
SMT202000601T1
(it)
*
|
2015-12-15 |
2021-01-05 |
Univ Leland Stanford Junior |
Metodo per prevenire e/o trattare il deterioramento cognitivo e la neuroinfiammazione associati all’invecchiamento
|
|
JP2021501203A
(ja)
|
2017-10-30 |
2021-01-14 |
アプトース バイオサイエンシズ インコーポレイテッド |
がん治療用のアリールイミダゾール
|
|
EP3833344A4
(en)
*
|
2018-08-06 |
2022-07-06 |
The Board of Trustees of the Leland Stanford Junior University |
2-ARYLBENZIMIDAZOLES USEFUL AS PPARGC1A ACTIVATORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
|